CELIAC DISEASE FOUNDATION
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$7,559,145
Investments
57%
Cash & Equivalents
27%
Property, Plant, & Equipment (net)
9%
Receivables (Non-Related)
6%
Other Assets
1%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$2,000,126
Payables & Accruals
47%
Grants Payable
37%
Deferred Revenue
16%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$1,615,687
$2,004,589
+24%
Receivables (Non-Related)
$678,538
$443,756
-35%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$21,336
$31,593
+48%
Investments
$3,352,031
$4,297,334
+28%
Property, Plant, & Equipment (net)
$212,053
$702,175
+231%
Other Assets
$80,209
$79,698
-1%
Total Assets
$5,959,854
$7,559,145
+27%
Liabilities
2023
2024
Change
Payables & Accruals
$159,090
$939,503
+491%
Grants Payable
$139,092
$734,092
+428%
Deferred Revenue
$335,608
$326,531
-3%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$0
-
-
Total Liabilities
$633,790
$2,000,126
+216%
Net assets
2023
2024
Change
Restricted Net Assets
$31,500
$0
-100%
Unrestricted Net Assets
$5,294,564
$5,559,019
+5%
Net assets
2023
2024
Change
Net assets
+$5,326,064
+$5,559,019
+4%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)